Services

Regulatory Affairs

Human Medicines

Regulatory affairs support across EU & worldwide markets

Our dedicated Regulatory Affairs team offers comprehensive support across the European Union and worldwide, covering every stage of your medicinal product’s journey. We bring deep expertise across a wide array of human-medicine types, including invoative medicines, generics, non-prescription (OTC), herbals, biosimilars, ATMPs, biologicals and orphan medicines.

From the earliest strategic planning for new-product development, through pre-submission interactions with regulators and dossier preparation, to post-approval lifecycle management, our regulatory affairs services are designed to help you achieve a competitive edge. We work collaboratively to craft effective regulatory strategies that align with business goals, navigate complex regulatory frameworks and expedite market access—all while maintaining the highest standards of safety, quality and compliance.

With our regulatory affairs expertise you benefit from a partner who not only understands the regulatory demands but also proactively anticipates changes in the global regulatory landscape and mitigates risk, enabling you to focus on innovation and growth. Our experience across multiple therapeutic areas allows us to adapt to the specific needs of each product, ensuring seamless coordination and compliance throughout its lifecycle. By combining technical precision with strategic insight, we help transform regulatory challenges into opportunities for faster, safer market success.

Navigating the complex and ever-changing regulatory landscape requires more than compliance — it demands foresight and experience. Our regulatory affairs experts combine scientific understanding with deep knowledge of European and global regulatory frameworks to help you bring your products to market efficiently and sustainably.

How to Reach us?

Billev farmacija vzhod, d. o. o.
Billev Pharma East Ltd.
Tržaška cesta 202

1000 Ljubljana

Slovenia

Whether you are preparing a new marketing authorization, managing variations, or maintaining product lifecycle documentation, our Regulatory Affairs specialists ensure clarity, accuracy, and alignment with agency expectations. We work closely with your teams to develop tailored solutions that reduce risk, shorten timelines, and support long-term market success.

Through proactive communication with regulatory authorities and consistent adherence to evolving legislation, we help you avoid delays, anticipate potential challenges, and optimize your regulatory submissions. Our team’s commitment to precision and transparency ensures that every step in the process supports your strategic objectives.

Partner with us to transform regulatory complexity into a clear pathway toward approval and growth.

Events

February 2025 – (Amsterdam): Our Billev Pharma East team took part in the 23rd Regulatory Affairs Conference (RAC25), organised by Medicines for Europe and held at the Hilton Amsterdam Airport Schiphol on 27–28 February 2025. RAC25 brought together regulators, industry leaders and EU stakeholders to explore the regulatory priorities shaping the off-patent medicines sector — with a strong focus on the evolving EU pharmaceutical framework, digitalisation of regulatory processes, and practical readiness for upcoming compliance and product-information changes. Read more

September–October 2025 – (Berlin): Our Billev Pharma East team joined the TOPRA Annual Symposium 2025, held in-person at the JW Marriott Hotel Berlin from 29 September to 1 October 2025. The symposium brought together regulatory affairs professionals across human medicines, veterinary medicines, and medical devices/IVDs, with an additional one-day regulatory update for start-ups, SMEs and academia. Across the programme, discussions focused on key priorities shaping the regulatory landscape — including the evolving EU framework, implementation challenges, and practical approaches to staying inspection- and submission-ready in a rapidly changing environment. Read more

November 2025 – (spletno): Our Billev Pharma East team recently hosted the free webinar Essential Tools and Techniques for Preparing Product Information Using QRD Templates. The event aimed to present the latest guidelines for drafting medicine-product information in line with European Medicines Agency (EMA) standards — using the standardized Quality Review of Documents (QRD) template to ensure consistent, clear and EU-compliant SmPCs, package leaflets and labelling. Read more

Regulatory affairs

Our services include consulting on:

Pre-submission process:

  •  Submission Strategy
  • Preparation of Modules 1-5
  • Choosing the most appropriate procedure type
  • Managing all types of registration procedures for various products in the eCTD.
  • Consultation on a legal basis and classification of products
  • Handling registration procedures in all EU Member States
  • Life-cycle management
  • Dossier Compilation & Submission to Regulatory Authorities
    for Marketing Regulatory Submissions through:
    • National Procedures (NP)
    • Mutual Recognition Procedures (MRP)
    • Decentralized Procedures (DCP)
    • Centralized Procedure (CP)

Post-approval process:

  • Regulatory Support & Submissions (Variations, Renewals)
  • CMC documentation preparation (API and FDF)
  • EDQM – obtaining CEP
  • Environmental risk assessment (ERA)
  • Product Information Adaptation (SmPC, labelling & PIL)
  • Artwork Review
  • Other Regulatory Translation Services
  • Facilitating communication with authorities

More ways,
we can help.

With a focus on expert guidance and strategic insights, we propel your projects forward with confidence, ensuring every step is handled with precision.

Don’t miss out

Follow us on LinkedIn

Watch our
promotional video

HOME

SERVICES

Regulatory Affairs

PharmacoVigilance

Medical Consultancy

Quality / GxP

Digital Consultancy

TEAM OF EXPERTS

ABOUT US

NEWS AND EVENTS

B2B PARTNER LOG-IN